A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis

被引:2
|
作者
Croft, Anthony [1 ,2 ,3 ]
Okano, Satomi [2 ]
Hartel, Gunter [2 ]
Lord, Anton [2 ]
Walker, Gareth [1 ,2 ,3 ]
Tambakis, George [1 ,2 ,3 ]
Radford-Smith, Graham [1 ,2 ,3 ]
机构
[1] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[3] Univ Queensland, Fac Med, Brisbane, Qld, Australia
关键词
INFLAMMATORY-BOWEL-DISEASE; ENDOSCOPIC INDEX; SALVAGE THERAPY; CYCLOSPORINE; COLECTOMY; OUTCOMES; TOFACITINIB; NEED;
D O I
10.1111/apt.18190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundAn episode of acute ulcerative colitis (UC) represents an important watershed moment in a patient's disease course.AimsTo derive a personalised algorithm for identifying patients at high risk of corticosteroid non-response from variables available at hospital presentation using a large prospectively collected acute UC patient database and machine learning-based techniques.MethodsWe analysed data from 682 consecutive presentations of acute UC. We used an Akaike information criterion-based elastic net model to select variables based on the 419 earliest presentations of acute UC (1996-2017). We constructed two risk-scoring algorithms, with and without utilising additional endoscopic variables, using logistic regression models. We validated these risk scores on separate cohorts of 181 (2018-2022) and 82 (2015-2022) acute UC presentations.ResultsThe partial risk of rescue (ROR) score included the admission indices of oral corticosteroid treatment, bowel frequency >= 6/24 h, albumin, CRP >= 12 mg/mL and log10CRP. The full ROR score incorporates the same variables with the addition of the Mayo endoscopic subscore and disease extent. The AUCs in the main validation cohort were 0.76 (95% CI: 0.69-0.83) and 0.78 (95% CI: 0.71-0.85) for the partial and full ROR scores, respectively.ConclusionsThese pragmatic personalised risk scores (available at ) have comparably strong performance characteristics and usability enabling the identification of individuals at high risk of corticosteroid non-response before or after endoscopic assessment. The ROR scores have the potential to challenge conventional acute UC treatment paradigms by identifying patients who may benefit from early rescue therapy or participation in relevant clinical trials. Partial and full risk of rescue (ROR) score derivation and validation. For online ROR score calculator visit image
引用
收藏
页码:921 / 933
页数:13
相关论文
共 50 条
  • [41] Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis
    Posner, Hannah
    Kayal, Maia
    Milwidsky, Hadar Meringer
    Plietz, Michael
    Khaitov, Sergey
    Sylla, Patricia
    Greenstein, Alexander J.
    Dubinsky, Marla C.
    Mehandru, Saurabh
    Colombel, Jean-Frederic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S699 - S699
  • [42] Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis
    Bernardo, Sonia
    Fernandes, Samuel Raimundo
    Goncalves, Ana Rita
    Valente, Ana
    Baldaia, Cilenia
    Santos, Paula Moura
    Correia, Luis Araujo
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (03) : 541 - 546
  • [43] Predicting response after infliximab salvage in acute severe ulcerative colitis
    Choy, Matthew C.
    Seah, Dean
    Gorelik, Alexandra
    An, Yoon-Kyo
    Chen, Cheng-Yu
    Macrae, Finlay A.
    Sparrow, Miles P.
    Connell, William R.
    Moore, Gregory T.
    Radford-Smith, Graham
    Van Langenberg, Daniel R.
    De Cruz, Peter
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (07) : 1347 - 1352
  • [44] Serum Protein Profiling Predicting Outcome in Acute Severe Ulcerative Colitis
    Hare, Nicola C.
    Imrie, Margaret
    Soo, Kimberley
    Smith, Amanda
    Gray, Robert
    Ho, Gwo-Tzer
    Arnott, Ian D.
    Satsangi, Jack
    GASTROENTEROLOGY, 2009, 136 (05) : A194 - A194
  • [45] Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
    Jiang, Wenyu
    Lu, Meijiao
    Zhang, Li
    Xu, Chenjing
    Wang, Ruohan
    Xu, Ying
    Tang, Wen
    Zhang, Hongjie
    MEDICINE, 2023, 102 (32) : E34729
  • [46] INTRAVENOUS TOBRAMYCIN AND METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN ACUTE, SEVERE ULCERATIVE-COLITIS
    MANTZARIS, GJ
    HATZIS, A
    KONTOGIANNIS, P
    TRIADAPHYLLOU, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1994, 89 (01): : 43 - 46
  • [47] INTRAVENOUS TOBRAMYCIN AND METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN ACUTE, SEVERE ULCERATIVE-COLITIS
    MANTZARIS, GJ
    HATZIS, A
    KONTOGIANNIS, P
    TRIANTAPHYLLOU, G
    GASTROENTEROLOGY, 1993, 104 (04) : A737 - A737
  • [48] Predict the risk of acute severe ulcerative colitis based on machine learning algorithm: A multicenter cohort study
    Qiu, Y.
    Rao, M.
    Peng, S.
    Zhang, C.
    Gao, X.
    Cao, Q.
    Ng, S. C.
    Chen, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1057 - i1057
  • [49] Predicting steroid failure in acute severe ulcerative colitis using the Admission Model for Intensification of Therapy in Acute Severe Colitis (ADMIT-ASC) in a regional health service
    Cosgrave, Carl
    Tamsett, Zacchary
    Flanagan, Eliza
    Withanage, Sahan
    Beattie, William
    Heerasing, Neel
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 167 - 168
  • [50] FAILURE OF ANTI-LYMPHOCYTIC GLOBULIN IN ACUTE ULCERATIVE-COLITIS
    HEYWORTH, MF
    TRUELOVE, SC
    LANCET, 1981, 1 (8228): : 1060 - 1061